Heritage Investors Management Corp Cuts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Heritage Investors Management Corp lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 0.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 7,943 shares of the biotechnology company’s stock after selling 44 shares during the period. Heritage Investors Management Corp’s holdings in Axon Enterprise were worth $4,721,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Groupama Asset Managment acquired a new position in Axon Enterprise during the 3rd quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $120,553,000. Westfield Capital Management Co. LP raised its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock worth $86,354,000 after acquiring an additional 111,405 shares during the period. Finally, Champlain Investment Partners LLC grew its stake in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. 5.70% of the stock is owned by company insiders.

Axon Enterprise Stock Up 15.3 %

Axon Enterprise stock opened at $572.40 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $43.65 billion, a PE ratio of 147.91, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The business has a 50 day simple moving average of $613.42 and a 200-day simple moving average of $522.06. Axon Enterprise, Inc. has a 12 month low of $265.32 and a 12 month high of $715.99.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on AXON. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Finally, Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $561.31.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.